TABLE OF CONTENTS

1. Introduction

1.1 The Insight Partners Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. North America Pharmacokinetics Services Market Landscape

4.1 PEST Analysis

5. North America Pharmacokinetics Services Market - Key Market Dynamics

5.1 Market Drivers

5.1.1 Rising Prevalence of Chronic and Infectious Diseases

5.1.2 Expanding Range of Application of Pharmacokinetic Studies

5.1.3 Outsourcing of Pharmacokinetics Services to CROs

5.2 Market Restraints

5.2.1 Limited Reach of Pharmacokinetics Service Providers in Emerging Countries

5.3 Market Opportunities

5.3.1 Increasing Adoption of In-Vivo and In-Vitro Models for Understanding Variability in Pharmacokinetics

5.4 Future Trend

5.4.1 Increasing Adoption of Big Data Analytics in Pharmacokinetics Services

5.5 Impact of Drivers and Restraints:

6. Pharmacokinetics Services Market - North America Analysis

6.1 North America Pharmacokinetics Services Market Revenue (US$ Million), 2021-2031

7. North America Pharmacokinetics Services Market Analysis - by Drug Type

7.1 Overview

7.2 Small Molecule

7.2.1 Overview

7.2.2 Small Molecule: North America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)

7.3 Large Molecule

7.3.1 Overview

7.3.2 Large Molecule: North America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)

7.4 Vaccines

7.4.1 Overview

7.4.2 Vaccines: North America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)

8. North America Pharmacokinetics Services Market Analysis - by Service Type

8.1 Overview

8.2 Pre-Clinical ADME and Human Studies

8.2.1 Overview

8.2.2 Pre-Clinical ADME and Human Studies: North America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)

8.3 PK/PD Analysis and Reporting

8.3.1 Overview

8.3.2 PK/PD Analysis and Reporting: North America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)

8.4 Dosing Simulations

8.4.1 Overview

8.4.2 Dosing Simulations: North America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)

8.5 Risk Analysis

8.5.1 Overview

8.5.2 Risk Analysis: North America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)

8.6 Others

8.6.1 Overview

8.6.2 Others: North America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)

9. North America Pharmacokinetics Services Market Analysis - by Therapeutic Application

9.1 Oncology

9.1.1 Overview

9.1.2 Oncology: North America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)

9.2 Infectious Diseases

9.2.1 Overview

9.2.2 Infectious Diseases: North America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)

9.3 Neurological Disorders

9.3.1 Overview

9.3.2 Neurological Disorders: North America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)

9.4 Autoimmune Diseases

9.4.1 Overview

9.4.2 Autoimmune Diseases: North America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)

9.5 Gynecological Disorders

9.5.1 Overview

9.5.2 Gynecological Disorders: North America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)

9.6 Cardiovascular Diseases

9.6.1 Overview

9.6.2 Cardiovascular Diseases: North America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)

9.7 Respiratory Disorders

9.7.1 Overview

9.7.2 Respiratory Disorders: North America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)

9.8 Others

9.8.1 Overview

9.8.2 Others: North America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)

10. North America Pharmacokinetics Services Market Analysis - by End User

10.1 Pharmaceutical and Biotechnology Companies

10.1.1 Overview

10.1.2 Pharmaceutical and Biotechnology Companies: North America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)

10.2 Contract Research Organization

10.2.1 Overview

10.2.2 Contract Research Organization: North America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)

10.3 Others

10.3.1 Overview

10.3.2 Others: North America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)

11. North America Pharmacokinetics Services Market - Country Analysis

11.1 North America

11.1.1 North America Pharmacokinetics Services Market Breakdown, by Key Countries, 2023 and 2031 (%)

11.1.1.1 United States: North America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)

11.1.1.1.1 Overview

11.1.1.1.2 United States: North America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)

11.1.1.1.3 United States: North America Pharmacokinetics Services Market Breakdown, by Drug Type

11.1.1.1.4 United States: North America Pharmacokinetics Services Market Breakdown, by Service Type

11.1.1.1.5 United States: North America Pharmacokinetics Services Market Breakdown, by Therapeutic Application

11.1.1.1.6 United States: North America Pharmacokinetics Services Market Breakdown, by End User

11.1.1.2 Canada: North America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)

11.1.1.2.1 Overview

11.1.1.2.2 Canada: North America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)

11.1.1.2.3 Canada: North America Pharmacokinetics Services Market Breakdown, by Drug Type

11.1.1.2.4 Canada: North America Pharmacokinetics Services Market Breakdown, by Service Type

11.1.1.2.5 Canada: North America Pharmacokinetics Services Market Breakdown, by Therapeutic Application

11.1.1.2.6 Canada: North America Pharmacokinetics Services Market Breakdown, by End User

11.1.1.3 Mexico: North America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)

11.1.1.3.1 Overview

11.1.1.3.2 Mexico: North America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)

11.1.1.3.3 Mexico: North America Pharmacokinetics Services Market Breakdown, by Drug Type

11.1.1.3.4 Mexico: North America Pharmacokinetics Services Market Breakdown, by Service Type

11.1.1.3.5 Mexico: North America Pharmacokinetics Services Market Breakdown, by Therapeutic Application

11.1.1.3.6 Mexico: North America Pharmacokinetics Services Market Breakdown, by End User

12. Company Profile

12.1 Charles River Laboratories International Inc

12.1.1 Key Facts

12.1.2 Business Description

12.1.3 Products and Services

12.1.4 Financial Overview

12.1.5 SWOT Analysis

12.1.6 Key Developments

12.2 Eurofins Scientific SE

12.2.1 Key Facts

12.2.2 Business Description

12.2.3 Products and Services

12.2.4 Financial Overview

12.2.5 SWOT Analysis

12.2.6 Key Developments

12.3 Evotec SE

12.3.1 Key Facts

12.3.2 Business Description

12.3.3 Products and Services

12.3.4 Financial Overview

12.3.5 SWOT Analysis

12.3.6 Key Developments

12.4 Certara Inc.

12.4.1 Key Facts

12.4.2 Business Description

12.4.3 Products and Services

12.4.4 Financial Overview

12.4.5 SWOT Analysis

12.5 Parexel International Corp

12.5.1 Key Facts

12.5.2 Business Description

12.5.3 Products and Services

12.5.4 Financial Overview

12.5.5 SWOT Analysis

12.5.6 Key Developments

12.6 Thermo Fisher Scientific Inc.

12.6.1 Key Facts

12.6.2 Business Description

12.6.3 Products and Services

12.6.4 Financial Overview

12.6.5 SWOT Analysis

12.6.6 Key Developments

12.7 Allucent

12.7.1 Key Facts

12.7.2 Business Description

12.7.3 Products and Services

12.7.4 Financial Overview

12.7.5 SWOT Analysis

12.7.6 Key Developments

12.8 PACIFIC BIOLABS

12.8.1 Key Facts

12.8.2 Business Description

12.8.3 Products and Services

12.8.4 Financial Overview

12.8.5 SWOT Analysis

12.8.6 Key Developments

12.9 SGS SA

12.9.1 Key Facts

12.9.2 Business Description

12.9.3 Products and Services

12.9.4 Financial Overview

12.9.5 SWOT Analysis

12.9.6 Key Developments

13. Appendix

13.1 About The Insight Partners

13.2 Glossary of Terms for Pharmacokinetic Services Market

List of Tables

Table 1. North America Pharmacokinetics Services Market Segmentation

Table 2. United States: North America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million) - by Drug Type

Table 3. United States: North America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million) - by Service Type

Table 4. United States: North America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million) - by Therapeutic Application

Table 5. United States: North America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million) - by End User

Table 6. Canada: North America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million) - by Drug Type

Table 7. Canada: North America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million) - by Service Type

Table 8. Canada: North America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million) - by Therapeutic Application

Table 9. Canada: North America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million) - by End User

Table 10. Mexico: North America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million) - by Drug Type

Table 11. Mexico: North America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million) - by Service Type

Table 12. Mexico: North America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million) - by Therapeutic Application

Table 13. Mexico: North America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million) - by End User

Table 14. Glossary of Terms

List of Figures

Figure 1. North America Pharmacokinetics Services Market Segmentation, by Country

Figure 2. PEST Analysis

Figure 3. North America Pharmacokinetics Services Market - Key Market Dynamics

Figure 4. Impact Analysis of Drivers and Restraints

Figure 5. North America Pharmacokinetics Services Market Revenue (US$ Million), 2021-2031

Figure 6. North America Pharmacokinetics Services Market Share (%) - by Drug Type (2023 and 2031)

Figure 7. Small Molecule: North America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)

Figure 8. Large Molecule: North America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)

Figure 9. Vaccines: North America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)

Figure 10. North America Pharmacokinetics Services Market Share (%) - by Service Type (2023 and 2031)

Figure 11. Pre-Clinical ADME and Human Studies: North America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)

Figure 12. PK/PD Analysis and Reporting: North America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)

Figure 13. Dosing Simulations: North America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)

Figure 14. Risk Analysis: North America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)

Figure 15. Others: North America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)

Figure 16. North America Pharmacokinetics Services Market Share (%) - by Therapeutic Application (2023 and 2031)

Figure 17. Oncology: North America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)

Figure 18. Infectious Diseases: North America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)

Figure 19. Neurological Disorders: North America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)

Figure 20. Autoimmune Diseases: North America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)

Figure 21. Gynecological Disorders: North America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)

Figure 22. Cardiovascular Diseases: North America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)

Figure 23. Respiratory Disorders: North America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)

Figure 24. Others: North America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)

Figure 25. North America Pharmacokinetics Services Market Share (%) - by End User (2023 and 2031)

Figure 26. Pharmaceutical and Biotechnology Companies: North America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)

Figure 27. Contract Research Organization: North America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)

Figure 28. Others: North America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)

Figure 29. North America Pharmacokinetics Services Market by Key Countries - Revenue (2023) (US$ Million)

Figure 30. North America Pharmacokinetics Services Market Breakdown, by Key Countries, 2023 and 2031 (%)

Figure 31. United States: North America Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)

Figure 32. Canada: North America Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million)

Figure 33. Mexico: North America Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million)